Cargando…

Clinical Characteristics, Management, and Outcomes of the Patients With ST-Segment Elevation Myocardial Infarction Before and During the COVID-19 Pandemic

BACKGROUND: The first case of coronavirus disease 2019 (COVID-19) in the United Arab Emirates (UAE) was reported on January 29, 2020. Various anecdotal reports suggest that fewer patients with ST-segment elevation myocardial infarction (STEMI) have been presented to the hospital during the COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Almatrooshi, Nadya, Khan, Zafar, Chakkittayil, Manju, AlJaabari, Samir, Elyazori, Yara, Nour, Seema, Alzubaidi, Abdul Majeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827238/
https://www.ncbi.nlm.nih.gov/pubmed/35211223
http://dx.doi.org/10.14740/cr1275
_version_ 1784647586572926976
author Almatrooshi, Nadya
Khan, Zafar
Chakkittayil, Manju
AlJaabari, Samir
Elyazori, Yara
Nour, Seema
Alzubaidi, Abdul Majeed
author_facet Almatrooshi, Nadya
Khan, Zafar
Chakkittayil, Manju
AlJaabari, Samir
Elyazori, Yara
Nour, Seema
Alzubaidi, Abdul Majeed
author_sort Almatrooshi, Nadya
collection PubMed
description BACKGROUND: The first case of coronavirus disease 2019 (COVID-19) in the United Arab Emirates (UAE) was reported on January 29, 2020. Various anecdotal reports suggest that fewer patients with ST-segment elevation myocardial infarction (STEMI) have been presented to the hospital during the COVID-19 pandemic. In this study, we examined the patient characteristics, in-hospital management, and outcomes of the patients with STEMI before and during the COVID-19 pandemic in Abu Dhabi, UAE. METHODS: We analyzed the data retrospectively from January 1, 2019 to December 31, 2020 and stratified the same into two periods: before the pandemic (January 1, 2019 to January 28, 2020) and during the pandemic (January 29, 2020 to December 31, 2020). The patient-level data for the two periods were compared to identify the differences in the patient characteristics, in-hospital management, and 30-day mortality outcomes of the patients with STEMI. RESULTS: During the COVID-19 pandemic, the number of STEMI cases was lower (n = 234) than before the pandemic (n = 266), and 11patients (4.7%) tested positive for COVID-19 during their hospital encounter. In comparison to before the pandemic, patients with STEMI were significantly younger (mean age: 50.39 years, standard deviation (SD) ± 10.32 years), less likely to present to the emergency department (ED), and more likely to have histories of hypercholesterolemia (P < 0.001) and coronary artery disease (P < 0.001). Significantly shorter door-to-balloon time (56.6 ± 27.26 min, P < 0.001) and decreased length of stay (4.7 ± 6.8 days, P < 0.001) were observed during the pandemic. However, no considerable difference in the 30-day mortality was observed in 2020 as compared to before the pandemic (2.1% versus 3.0%, respectively). CONCLUSIONS: Hospital presentation for the patients with STEMI decreased during the COVID-19 pandemic, with significant differences in the door-to-balloon time and length of hospital stay. This indicates that the hospital systems of care continued to operate with higher efficiency during the COVID-19 pandemic than before the pandemic in the UAE.
format Online
Article
Text
id pubmed-8827238
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-88272382022-02-23 Clinical Characteristics, Management, and Outcomes of the Patients With ST-Segment Elevation Myocardial Infarction Before and During the COVID-19 Pandemic Almatrooshi, Nadya Khan, Zafar Chakkittayil, Manju AlJaabari, Samir Elyazori, Yara Nour, Seema Alzubaidi, Abdul Majeed Cardiol Res Original Article BACKGROUND: The first case of coronavirus disease 2019 (COVID-19) in the United Arab Emirates (UAE) was reported on January 29, 2020. Various anecdotal reports suggest that fewer patients with ST-segment elevation myocardial infarction (STEMI) have been presented to the hospital during the COVID-19 pandemic. In this study, we examined the patient characteristics, in-hospital management, and outcomes of the patients with STEMI before and during the COVID-19 pandemic in Abu Dhabi, UAE. METHODS: We analyzed the data retrospectively from January 1, 2019 to December 31, 2020 and stratified the same into two periods: before the pandemic (January 1, 2019 to January 28, 2020) and during the pandemic (January 29, 2020 to December 31, 2020). The patient-level data for the two periods were compared to identify the differences in the patient characteristics, in-hospital management, and 30-day mortality outcomes of the patients with STEMI. RESULTS: During the COVID-19 pandemic, the number of STEMI cases was lower (n = 234) than before the pandemic (n = 266), and 11patients (4.7%) tested positive for COVID-19 during their hospital encounter. In comparison to before the pandemic, patients with STEMI were significantly younger (mean age: 50.39 years, standard deviation (SD) ± 10.32 years), less likely to present to the emergency department (ED), and more likely to have histories of hypercholesterolemia (P < 0.001) and coronary artery disease (P < 0.001). Significantly shorter door-to-balloon time (56.6 ± 27.26 min, P < 0.001) and decreased length of stay (4.7 ± 6.8 days, P < 0.001) were observed during the pandemic. However, no considerable difference in the 30-day mortality was observed in 2020 as compared to before the pandemic (2.1% versus 3.0%, respectively). CONCLUSIONS: Hospital presentation for the patients with STEMI decreased during the COVID-19 pandemic, with significant differences in the door-to-balloon time and length of hospital stay. This indicates that the hospital systems of care continued to operate with higher efficiency during the COVID-19 pandemic than before the pandemic in the UAE. Elmer Press 2022-02 2021-12-28 /pmc/articles/PMC8827238/ /pubmed/35211223 http://dx.doi.org/10.14740/cr1275 Text en Copyright 2022, Almatrooshi et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Almatrooshi, Nadya
Khan, Zafar
Chakkittayil, Manju
AlJaabari, Samir
Elyazori, Yara
Nour, Seema
Alzubaidi, Abdul Majeed
Clinical Characteristics, Management, and Outcomes of the Patients With ST-Segment Elevation Myocardial Infarction Before and During the COVID-19 Pandemic
title Clinical Characteristics, Management, and Outcomes of the Patients With ST-Segment Elevation Myocardial Infarction Before and During the COVID-19 Pandemic
title_full Clinical Characteristics, Management, and Outcomes of the Patients With ST-Segment Elevation Myocardial Infarction Before and During the COVID-19 Pandemic
title_fullStr Clinical Characteristics, Management, and Outcomes of the Patients With ST-Segment Elevation Myocardial Infarction Before and During the COVID-19 Pandemic
title_full_unstemmed Clinical Characteristics, Management, and Outcomes of the Patients With ST-Segment Elevation Myocardial Infarction Before and During the COVID-19 Pandemic
title_short Clinical Characteristics, Management, and Outcomes of the Patients With ST-Segment Elevation Myocardial Infarction Before and During the COVID-19 Pandemic
title_sort clinical characteristics, management, and outcomes of the patients with st-segment elevation myocardial infarction before and during the covid-19 pandemic
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827238/
https://www.ncbi.nlm.nih.gov/pubmed/35211223
http://dx.doi.org/10.14740/cr1275
work_keys_str_mv AT almatrooshinadya clinicalcharacteristicsmanagementandoutcomesofthepatientswithstsegmentelevationmyocardialinfarctionbeforeandduringthecovid19pandemic
AT khanzafar clinicalcharacteristicsmanagementandoutcomesofthepatientswithstsegmentelevationmyocardialinfarctionbeforeandduringthecovid19pandemic
AT chakkittayilmanju clinicalcharacteristicsmanagementandoutcomesofthepatientswithstsegmentelevationmyocardialinfarctionbeforeandduringthecovid19pandemic
AT aljaabarisamir clinicalcharacteristicsmanagementandoutcomesofthepatientswithstsegmentelevationmyocardialinfarctionbeforeandduringthecovid19pandemic
AT elyazoriyara clinicalcharacteristicsmanagementandoutcomesofthepatientswithstsegmentelevationmyocardialinfarctionbeforeandduringthecovid19pandemic
AT nourseema clinicalcharacteristicsmanagementandoutcomesofthepatientswithstsegmentelevationmyocardialinfarctionbeforeandduringthecovid19pandemic
AT alzubaidiabdulmajeed clinicalcharacteristicsmanagementandoutcomesofthepatientswithstsegmentelevationmyocardialinfarctionbeforeandduringthecovid19pandemic